Fidelity's India-based private equity unit reportedly led the round raised by the seven year old drug discovery company.
Fideilty Growth Partners India, an India-based private equity unit of the asset manager, helped India-based pharmaceutical company Aptuit Laurus last month.
Aptuit Laurus raised the funds, according to news provider VC Circle. The company was founded in 2005, and works across all areas of drug development, according to its website.
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
